Many people with diabetes who can't afford the insulin they need to stay alive are turning to social media for help.
In other developed countries, affordability is far less of an issue.
Lawmakers have been critical of big pharma's pricing structures.
Three of the biggest makers of diabetes treatments have been accused of price fixing. A lawsuit filed this week claims that Sanofi, Novo Nordisk and Eli Lilly have been conspiring to drive up prices of insulin at the expense of their patients. Because of the high prices, the suit says some patients have been using […]